The global market for Plant Disease Diagnostics was estimated at US$100.6 Million in 2024 and is projected to reach US$120.8 Million by 2030, growing at a CAGR of 3.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Plant Disease Diagnostics market.
Common diagnostic methods include visual assessment, culture-based assays, molecular techniques such as PCR, ELISA tests, and newer tools like loop-mediated isothermal amplification (LAMP). These methods help identify latent infections and confirm disease presence at an early stage, minimizing spread and economic impact. Diagnostic tools are used across a wide range of crops including cereals, fruits, vegetables, and plantation crops.
Remote sensing tools, drones, and AI-based image analytics are complementing molecular diagnostics by identifying disease patterns at scale. Lab-on-chip platforms and lateral flow devices are improving speed and usability of field-level tests. Public and private agricultural institutions are increasingly developing pathogen-specific kits and mobile diagnostics for farmer-level access in both advanced and emerging economies.
North America and Europe have mature diagnostic infrastructure supported by academic and industrial research. Asia-Pacific and Latin America are experiencing rapid growth in adoption due to rising awareness, government crop health programs, and commercial farming expansion. Seed producers, horticulture growers, and agrochemical companies are major users of diagnostic tools for quality assurance and crop protection.
Expansion of protected farming, government focus on biosecurity, and growth in precision agriculture are fueling demand for proactive disease monitoring tools. Adoption in seed certification, regulatory screening, and smart farming platforms is also contributing to market growth. Continued investment in rapid pathogen detection, mobile testing systems, and digitally enabled diagnostics is expected to sustain momentum across crop sectors and geographies.
Segments: Product Type (Diagnostic Kits, Lateral Flow Devices, DNA / RNA Probes, Accessories & Other Consumables, Software & Cloud Database); Test (Molecular Test, Serological Test, Test Using Electronic Technology); Sample (Seeds Sample, Grains Sample, Plants Sample, Trees Sample, Fruits Sample, Other Samples); End-Use (Agricultural Laboratories End-Use, Academic & Research Institutes End-Use, Food Processing Laboratories End-Use, Contract Research Organization End-Use, Other End-Uses)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Global Plant Disease Diagnostics Market - Key Trends & Drivers Summarized
Why Is Accurate Disease Diagnosis Critical to Modern Agriculture?
Plant disease diagnostics is a vital aspect of crop protection and sustainable agriculture. Early and precise identification of pathogens, including fungi, bacteria, viruses, and nematodes, helps prevent yield losses, reduces overuse of pesticides, and supports targeted treatment strategies. Traditional field scouting is being augmented by diagnostic kits and laboratory tools that enable faster and more accurate detection.Common diagnostic methods include visual assessment, culture-based assays, molecular techniques such as PCR, ELISA tests, and newer tools like loop-mediated isothermal amplification (LAMP). These methods help identify latent infections and confirm disease presence at an early stage, minimizing spread and economic impact. Diagnostic tools are used across a wide range of crops including cereals, fruits, vegetables, and plantation crops.
How Are Diagnostic Technologies Evolving in Accuracy and Accessibility?
Molecular diagnostics are gaining traction due to their high sensitivity and specificity. Real-time PCR and portable biosensors are being integrated into field kits that allow growers and agronomists to detect pathogens on-site. Next-generation sequencing (NGS) is also emerging in research and breeding programs to study complex disease interactions and emerging pathogens.Remote sensing tools, drones, and AI-based image analytics are complementing molecular diagnostics by identifying disease patterns at scale. Lab-on-chip platforms and lateral flow devices are improving speed and usability of field-level tests. Public and private agricultural institutions are increasingly developing pathogen-specific kits and mobile diagnostics for farmer-level access in both advanced and emerging economies.
Where Is Adoption Expanding and What Crops Are Prioritized for Diagnostics?
Diagnostic tools are widely used in high-value crops such as grapes, apples, bananas, potatoes, and citrus, where disease outbreaks can cause significant export and market losses. Global trade in agricultural products has increased the risk of cross-border pathogen spread, prompting regulatory agencies to implement stricter diagnostic and quarantine protocols.North America and Europe have mature diagnostic infrastructure supported by academic and industrial research. Asia-Pacific and Latin America are experiencing rapid growth in adoption due to rising awareness, government crop health programs, and commercial farming expansion. Seed producers, horticulture growers, and agrochemical companies are major users of diagnostic tools for quality assurance and crop protection.
Growth in the Plant Disease Diagnostics market is driven by several factors
Growth in the plant disease diagnostics market is driven by rising global incidences of crop diseases, increasing demand for residue-free food, and the need for rapid, accurate detection technologies. Adoption of portable molecular diagnostics, integration of image-based disease recognition systems, and development of cost-effective field kits are enabling broader accessibility.Expansion of protected farming, government focus on biosecurity, and growth in precision agriculture are fueling demand for proactive disease monitoring tools. Adoption in seed certification, regulatory screening, and smart farming platforms is also contributing to market growth. Continued investment in rapid pathogen detection, mobile testing systems, and digitally enabled diagnostics is expected to sustain momentum across crop sectors and geographies.
Scope Of Study:
The report analyzes the Plant Disease Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:Segments: Product Type (Diagnostic Kits, Lateral Flow Devices, DNA / RNA Probes, Accessories & Other Consumables, Software & Cloud Database); Test (Molecular Test, Serological Test, Test Using Electronic Technology); Sample (Seeds Sample, Grains Sample, Plants Sample, Trees Sample, Fruits Sample, Other Samples); End-Use (Agricultural Laboratories End-Use, Academic & Research Institutes End-Use, Food Processing Laboratories End-Use, Contract Research Organization End-Use, Other End-Uses)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Diagnostic Kits segment, which is expected to reach US$56.6 Million by 2030 with a CAGR of a 4.0%. The Lateral Flow Devices segment is also set to grow at 2.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $27.4 Million in 2024, and China, forecasted to grow at an impressive 6.0% CAGR to reach $24.0 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Plant Disease Diagnostics Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Plant Disease Diagnostics Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Plant Disease Diagnostics Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Abingdon Health, Agdia, Inc., Agritest S.r.l., BioDiagnostics, Inc., BIOREBA AG and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 48 companies featured in this Plant Disease Diagnostics market report include:
- Abingdon Health
- Agdia, Inc.
- Agritest S.r.l.
- BioDiagnostics, Inc.
- BIOREBA AG
- Biorex Food Diagnostics
- Clear Labs
- Creative Diagnostics
- Diagnostics for the Real World
- DNA Gensee
- Envirologix Inc.
- Eurofins Scientific
- Fera Science Ltd.
- GeneReach Biotechnology Corp.
- ICRISAT (Plant Diagnostics Lab)
- Loewe Biochemica GmbH
- Norgen Biotek Corp.
- Qualiplante
- Romer Labs
- TwistDx (part of Abbott)
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abingdon Health
- Agdia, Inc.
- Agritest S.r.l.
- BioDiagnostics, Inc.
- BIOREBA AG
- Biorex Food Diagnostics
- Clear Labs
- Creative Diagnostics
- Diagnostics for the Real World
- DNA Gensee
- Envirologix Inc.
- Eurofins Scientific
- Fera Science Ltd.
- GeneReach Biotechnology Corp.
- ICRISAT (Plant Diagnostics Lab)
- Loewe Biochemica GmbH
- Norgen Biotek Corp.
- Qualiplante
- Romer Labs
- TwistDx (part of Abbott)
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 498 |
Published | July 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value in 2024 | 100.6 Million |
Forecasted Market Value by 2030 | 120.8 Million |
Compound Annual Growth Rate | 3.1% |
Regions Covered | Global |